Pancreatic Cancer Trial, By Invitation (NCT06774170)

Pancreatic Cancer Trial, By Invitation NCT06774170 Sponsor: Dokuz Eylul University Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06774170 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You own and use a smartphone that works with the Dexcom G6 app
You have access to the internet
You scored above a certain level on a short memory and thinking test (the exact score required depends on your level of education — confirm with trial site)
You are willing to take part in the study
You have had a specific type of surgery called a pancreaticoduodenectomy (an operation involving the pancreas and nearby organs)
You may join whether or not you had Type 2 diabetes before your surgery

Who may not be able to join:

You developed a serious body-wide infection (sepsis) after your surgery
You were diagnosed before surgery with a condition called insulinoma, glucagonoma, or ectopic ACTH syndrome (hormone-related conditions — confirm with trial site if unsure)
You have been diagnosed with a psychiatric (mental health) illness
You have been clinically diagnosed with Alzheimer's Disease
You are currently staying in hospital as an inpatient

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06774170

Sponsor: Dokuz Eylul University

Phase: Not Applicable

Status: By Invitation

Condition: Pancreatic Cancer

More information: https://clinicaltrials.gov/study/NCT06774170

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You own and use a smartphone that works with the Dexcom G6 app
You have access to the internet
You scored above a certain level on a short memory and thinking test (the exact score required depends on your level of education — confirm with trial site)
You are willing to take part in the study
You have had a specific type of surgery called a pancreaticoduodenectomy (an operation involving the pancreas and nearby organs)
You may join whether or not you had Type 2 diabetes before your surgery

Who may not be able to join:

You developed a serious body-wide infection (sepsis) after your surgery
You were diagnosed before surgery with a condition called insulinoma, glucagonoma, or ectopic ACTH syndrome (hormone-related conditions — confirm with trial site if unsure)
You have been diagnosed with a psychiatric (mental health) illness
You have been clinically diagnosed with Alzheimer's Disease
You are currently staying in hospital as an inpatient

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

By Invitation

Phase

Not Applicable

Sponsor

Dokuz Eylul University

Registry

ClinicalTrials.gov

Start date

1 April 2024

Est. completion

1 November 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

HbA1c; fasting blood glucose; mean glucose; glucose standard deviation; glucose variance coefficient; GMI-glucose management indicator; time spent at the target glucose value (Time in range)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov